A Review on: Smart Polymers used in Novel Ophthalmic Drug Delivery System

Loss of sight or vision loss are utmost concerned worldwide health problems resulting in significant financial and public loss. Eyesight helps one to capture signals from the surrounding environment and depict clear visual images. Drug delivery to the eyes has been seen as a significant task for the reason that an eye has different defensive boundaries and drug clearance system resulting from an exceptional structural and functional nature of eyes. Formulation administered into the eye in the form of regular ophthalmic formulations leads to less absorption of drug. Therefore, approaches have been carried out to advance a novel, nontoxic and effective ophthalmic drug delivery system to control the difficulties occurring by the regular formulations. Latest innovation in pharmaceutical drug design has produced stimuli responsive in-situ gel system providing continuous release action and increased ocular drug bioavailability. They act by undergoing phase conversion from solution to gel owing to the variation in ocular temperature, ions and pH in the ocular environment. Stimuli transformed gel is formed in the region of cul de sac thus combating the limitations of regular ophthalmic formulations such as less retention time and fast nasolacrimal drainage within the eyes.

[1]  Manisha Pandey,et al.  Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research , 2021, Polymers.

[2]  S. Dubey,et al.  Nanocarriers for ocular drug delivery: current status and translational opportunity , 2020, RSC advances.

[3]  Z. Mansouri,et al.  Development of thermosensitive in situ gel nanoemulsions for ocular delivery of acyclovir , 2020, Journal of Drug Delivery Science and Technology.

[4]  Abeer M. Khattab,et al.  Development of optimized mucoadhesive thermosensitive pluronic based in situ gel for controlled delivery of Latanoprost: Antiglaucoma efficacy and stability approaches , 2019, Journal of Drug Delivery Science and Technology.

[5]  P. Boonme,et al.  Lidocaine loaded gelatin/gelatinized tapioca starch films for buccal delivery and the irritancy evaluation using chick chorioallantoic membrane , 2019, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[6]  K. Dua,et al.  Formulation and Characterization of pH Induced in situ Gels Containing Sulfacetamide Sodium for Ocular Drug Delivery: A Combination of Carbopol®/ HPMC Polymer , 2019, Indian Journal of Pharmaceutical Education and Research.

[7]  K. Koteshwara,et al.  Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation , 2019, AAPS PharmSciTech.

[8]  F. D. Guerra,et al.  Stimuli-Responsive Drug Release from Smart Polymers , 2019, Journal of functional biomaterials.

[9]  A. Ahmed,et al.  DEVELOPMENT, EVALUATION AND CHARACTERISTICS OF OPHTHALMIC IN SITU GEL SYSTEM: A REVIEW , 2019, International Journal of Current Pharmaceutical Research.

[10]  M. Kouchak,et al.  Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation , 2019, AAPS PharmSciTech.

[11]  Vrinda Gote,et al.  Ocular Drug Delivery: Present Innovations and Future Challenges , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[12]  M. Koland,et al.  DEVELOPMENT AND EVALUATION OF AN IN SITU THERMOGELLING SYSTEM OF OFLOXACIN FOR CONTROLLED OCULAR DELIVERY , 2019, Asian Journal of Pharmaceutical and Clinical Research.

[13]  N. Okur,et al.  Improving therapeutic efficacy of voriconazole against fungal keratitis: Thermo-sensitive in situ gels as ophthalmic drug carriers , 2019, Journal of Drug Delivery Science and Technology.

[14]  Yuanyuan Liu,et al.  Research progress of in-situ gelling ophthalmic drug delivery system , 2018, Asian journal of pharmaceutical sciences.

[15]  H. Kassab,et al.  PREPARATION AND IN VITRO EVALUATION OF NAPROXEN AS A pH SENSITIVE OCULAR IN-SITU GEL , 2019, International Journal of Applied Pharmaceutics.

[16]  Bappaditya Chatterjee,et al.  pH responsive polymers in drug delivery , 2018 .

[17]  Nasrul Wathoni,et al.  APPLICATION AND CHARACTERIZATION OF IN SITU GEL , 2018, International Journal of Applied Pharmaceutics.

[18]  Ying Huang,et al.  Thermo‐sensitive gel in glaucoma therapy for enhanced bioavailability: In vitro characterization, in vivo pharmacokinetics and pharmacodynamics study , 2018, Life sciences.

[19]  S. N. Bukhari,et al.  Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment , 2018, Artificial cells, nanomedicine, and biotechnology.

[20]  W. Pan,et al.  A novel ion-activated in situ gelling ophthalmic delivery system based on κ-carrageenan for acyclovir , 2018, Drug development and industrial pharmacy.

[21]  Zhidong Liu,et al.  Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits , 2018, Pharmaceutical development and technology.

[22]  Rinda Devi Bachu,et al.  Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases , 2018, Pharmaceutics.

[23]  Karthik Yadav Janga,et al.  Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation , 2018, Artificial cells, nanomedicine, and biotechnology.

[24]  Jingfen Sun,et al.  A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation , 2018, Drug design, development and therapy.

[25]  A. Concheiro,et al.  Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery. , 2018, Molecular pharmaceutics.

[26]  H. Fessi,et al.  Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review , 2018, Pharmaceutics.

[27]  A. Seyfoddin,et al.  Ophthalmic gels: Past, present and future , 2017, Advanced drug delivery reviews.

[28]  V. Pillay,et al.  Stimuli-responsive polymers as smart drug delivery systems: Classifications based on carrier type and triggered-release mechanism , 2018 .

[29]  David S. Jones,et al.  Minimally invasive microneedles for ocular drug delivery , 2017, Expert opinion on drug delivery.

[30]  Bhupinder Singh,et al.  Stimuli-Responsive Systems with Diverse Drug Delivery and Biomedical Applications: Recent Updates and Mechanistic Pathways. , 2017, Critical reviews in therapeutic drug carrier systems.

[31]  S. Doktorovová,et al.  Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  V. Pillay,et al.  Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery , 2016, Molecules.

[33]  S. Kant,et al.  Therapeutic Effectiveness in the Treatment of Experimental Bacterial Keratitis with Ion-activated Mucoadhesive Hydrogel , 2015, Ocular immunology and inflammation.

[34]  A. Mitra,et al.  Ocular Drug Delivery , 1990 .

[35]  Hongming Chen,et al.  Recent developments in ocular drug delivery* , 2015, Journal of drug targeting.

[36]  S. S. Imam,et al.  Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization , 2015, Pharmaceutical development and technology.

[37]  Asgar Ali,et al.  Physiologically active hydrogel (in situ gel) of sparfloxacin and its evaluation for ocular retention using gamma scintigraphy , 2015, Journal of pharmacy & bioallied sciences.

[38]  S. Shahi,et al.  Triggered In-Situ Gel : Formulation Development and Evaluation of In Situ Ophthalmic Gel of Olopatadine Hydrochloride , 2015 .

[39]  S. Saini,et al.  IN SITU GELS-A NEW TRENDS IN OPHTHALMIC DRUG DELIVERY SYSTEMS , 2015 .

[40]  Dean Ho,et al.  Diamond Nanogel-Embedded Contact Lenses Mediate Lysozyme-Dependent Therapeutic Release , 2014, ACS nano.

[41]  A. Mitra,et al.  Ocular drug delivery systems: An overview. , 2013, World journal of pharmacology.

[42]  A. Mitra,et al.  Eye: anatomy, physiology and barriers to drug delivery , 2013 .

[43]  S. Arora,et al.  Ocular drug delivery system: a reference to natural polymers , 2012, Expert opinion on drug delivery.

[44]  Cheryl Williams,et al.  Advances in Ocular Drug Delivery , 2012, Current eye research.

[45]  Sanyog Jain,et al.  In situ gel systems as ‘smart’ carriers for sustained ocular drug delivery , 2012, Expert opinion on drug delivery.

[46]  S. Young,et al.  Environment-sensitive polymers for ophthalmic drug delivery , 2012 .

[47]  A. Tagalpallewar,et al.  A NOVEL OPHTHALMIC DRUG DELIVERY SYSTEM: IN-SITU GEL , 2012 .

[48]  Shinobu Fujii,et al.  Recent Advances in Ocular Drug Delivery Systems , 2011 .

[49]  V. Kadam,et al.  Smart Polymers and Their Role in Drug Delivery: A Review , 2010 .

[50]  J. Lehel,et al.  HET-CAM test for determining the possible eye irritancy of pesticides. , 2010, Acta veterinaria Hungarica.

[51]  Yadollah Omidi,et al.  Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function – a review , 2010 .

[52]  Y. Omidi,et al.  Ocular novel drug delivery: impacts of membranes and barriers. , 2008, Expert opinion on drug delivery.

[53]  J. Fischbarg The biology of the eye , 2006 .

[54]  P. M’s,et al.  In-Situ gel: New trends in Controlled and Sustained Drug Delivery System , 2003 .

[55]  J. Sandford-Smith Basic Anatomy and Physiology of the Eye , 1990 .

[56]  Kazuhito Watanabe,et al.  Drug delivery to the eye. , 1982, Pharmacology & therapeutics.

[57]  Anoop Narayanan,et al.  Smart In situ Gels for Glaucoma-An Overview , 2022 .